Live
Read now

YoungHeartValve

Polymeric TAVR Heart Valve Technology

health AI/biotech medtech—cardiovascular devices (TAVR)
Raised$6.5 million
Employees5
LocationAtlanta, GA

About

YoungHeartValve's market-disruptive, durable biopolymeric technology, with worldwide exclusive rights, is poised to set a new standard for the growing market of low-risk patients.

Product

Value proposition
Tissue-free, hyaluronan-enhanced polymer leaflets designed to resist thrombosis and calcification with scalable, animal-free manufacturing for multiple valve indications

Founders

  • Lakshmi Prasad Dasi, Ph.D. — Co-Founder and CTO
  • Susan James, Ph.D. — Co-Founder and COO

Products

Biopolymer Leaflet TAVR Valve

Key features

Biopolymer leaflets built for enduranceBalloon expandable, low-profile deliveryProprietary dynamic sealing technology to reduce paravalvular leakageScalable manufacturing without animal tissueHylauronan-enhanced polymer technology for thrombosis/calcification resistance

Technologies

Hylauronan-enhanced polymer leafletsTAVR (transcatheter aortic valve replacement)Dynamic sealing technologySynthetic, animal-free manufacturingInterpenetrating network biomaterial

Traction metrics

3 patents approved or pending in US and worldwideNIH SBIR Phase 1 fundraising (raised $450K)

Investors

National Institutes of Health (NIH) (via SBIR grants)

News

More links

Browse similar startups

Related startups

Profile updated Jul 29, 2026. Sources: youngheartvalve.com

ClinAdsby ClinsightBuilt for clinics

Your clinic’s marketing team, powered by AI.

On-brand ads, SEO, and social campaigns in one place.

Generate your first clinic ad for free
Clincyby ClinsightBuilt for practices

Get more revenue from the patients you already have.

Voice and SMS that follow up until lapsed patients are back on the schedule.

Book a Clincy call
DDS RecruitPowered by ClinsightDental recruiting

Your practice’s fractional recruiting team.

Dental-only search, run end to end, with placements guaranteed for a year.

Find your next hire